SK283422B6 - Spôsob prípravy 3-etyl-5-metyl-2-(2-aminoetoxymetyl)-4-(2- chlórfenyl)-6-metyl-1,4-dihydro-3,5-pyridíndikarboxylátovej soli benzénsulfónovej kyseliny a medziprodukty na jej prípravu - Google Patents
Spôsob prípravy 3-etyl-5-metyl-2-(2-aminoetoxymetyl)-4-(2- chlórfenyl)-6-metyl-1,4-dihydro-3,5-pyridíndikarboxylátovej soli benzénsulfónovej kyseliny a medziprodukty na jej prípravu Download PDFInfo
- Publication number
- SK283422B6 SK283422B6 SK1045-98A SK104598A SK283422B6 SK 283422 B6 SK283422 B6 SK 283422B6 SK 104598 A SK104598 A SK 104598A SK 283422 B6 SK283422 B6 SK 283422B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- methyl
- ethyl
- organic solvent
- process according
- Prior art date
Links
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title claims description 49
- 230000008569 process Effects 0.000 title claims description 37
- 238000002360 preparation method Methods 0.000 title claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title abstract 6
- 150000007942 carboxylates Chemical class 0.000 title abstract 3
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 title abstract 3
- 125000001309 chloro group Chemical group Cl* 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title description 23
- WWIWLTSSHDKOKO-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1.OS(=O)(=O)C1=CC=CC=C1 WWIWLTSSHDKOKO-UHFFFAOYSA-N 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229940092714 benzenesulfonic acid Drugs 0.000 claims abstract description 21
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims abstract description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 36
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 36
- 239000003960 organic solvent Substances 0.000 claims description 23
- 230000015572 biosynthetic process Effects 0.000 claims description 22
- 238000009835 boiling Methods 0.000 claims description 21
- 150000003839 salts Chemical group 0.000 claims description 21
- 238000003786 synthesis reaction Methods 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000460 chlorine Substances 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 229910052801 chlorine Inorganic materials 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- GIGQADAFYQQKLX-UHFFFAOYSA-N ethyl 4-(2-chloroethoxy)-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)COCCCl GIGQADAFYQQKLX-UHFFFAOYSA-N 0.000 claims description 15
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 14
- -1 2-aminoethoxymethyl Chemical group 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical group [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 12
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 9
- HVIAZYLTLJYOJU-UHFFFAOYSA-N 1-(2-chloroethoxy)-2h-pyridine Chemical class ClCCON1CC=CC=C1 HVIAZYLTLJYOJU-UHFFFAOYSA-N 0.000 claims description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- XKORCTIIRYKLLG-ARJAWSKDSA-N methyl (z)-3-aminobut-2-enoate Chemical compound COC(=O)\C=C(\C)N XKORCTIIRYKLLG-ARJAWSKDSA-N 0.000 claims description 5
- ARFGCFFWYYOSFY-UHFFFAOYSA-N 1-(2-iodoethoxy)-2h-pyridine Chemical class ICCON1CC=CC=C1 ARFGCFFWYYOSFY-UHFFFAOYSA-N 0.000 claims description 4
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 239000012442 inert solvent Substances 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- RAIYODFGMLZUDF-UHFFFAOYSA-N piperidin-1-ium;acetate Chemical compound CC([O-])=O.C1CC[NH2+]CC1 RAIYODFGMLZUDF-UHFFFAOYSA-N 0.000 claims description 4
- 239000003586 protic polar solvent Substances 0.000 claims description 4
- 235000009518 sodium iodide Nutrition 0.000 claims description 4
- 125000006012 2-chloroethoxy group Chemical group 0.000 claims description 3
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 claims description 3
- 238000005882 aldol condensation reaction Methods 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- MGDWUTQKXCZNAJ-UHFFFAOYSA-N ethyl 4-bromo-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CBr MGDWUTQKXCZNAJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002798 polar solvent Substances 0.000 claims description 3
- NWDQBIRZEWCIMO-UHFFFAOYSA-N 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethyl-5,6-dimethylpiperidine-3,5-dicarboxylic acid Chemical class CCC1(C(O)=O)C(COCCN)NC(C)C(C)(C(O)=O)C1C1=CC=CC=C1Cl NWDQBIRZEWCIMO-UHFFFAOYSA-N 0.000 claims description 2
- 230000029936 alkylation Effects 0.000 claims description 2
- 238000005804 alkylation reaction Methods 0.000 claims description 2
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- JNFLAKLIDCFSHC-UHFFFAOYSA-N OS(=O)(=O)C1=CC=CC=C1.OC(=O)C1=CN=CC(C(O)=O)=C1 Chemical compound OS(=O)(=O)C1=CC=CC=C1.OC(=O)C1=CN=CC(C(O)=O)=C1 JNFLAKLIDCFSHC-UHFFFAOYSA-N 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 6
- 239000007795 chemical reaction product Substances 0.000 abstract description 4
- 150000008107 benzenesulfonic acids Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 13
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 13
- 229960004005 amlodipine besylate Drugs 0.000 description 13
- ZEYZVDNRETZDPT-UHFFFAOYSA-N ethyl 4-(2-chloroethoxy)-2-[(2-chlorophenyl)methylidene]-3-oxobutanoate Chemical compound ClCCOCC(=O)C(C(=O)OCC)=CC1=CC=CC=C1Cl ZEYZVDNRETZDPT-UHFFFAOYSA-N 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- FUZWYNSBUVRIAE-UHFFFAOYSA-N CC1C(C(C(=C(N1)COCCCl)C(=O)O)C2=CC=CC=C2Cl)(C)C(=O)O Chemical compound CC1C(C(C(=C(N1)COCCCl)C(=O)O)C2=CC=CC=C2Cl)(C)C(=O)O FUZWYNSBUVRIAE-UHFFFAOYSA-N 0.000 description 8
- 238000000921 elemental analysis Methods 0.000 description 8
- 229960000528 amlodipine Drugs 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- ATPFRGQBOVFFQM-WJIDAKASSA-N [(1s,3r,7r,8r,8as)-3-(hydroxymethyl)-8-[2-[(2r,4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate Chemical compound C([C@@H]1[C@H](C)C=CC2=C[C@H](CO)C[C@@H]([C@@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 ATPFRGQBOVFFQM-WJIDAKASSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- LLKNNWAVRRHMMC-UHFFFAOYSA-N ethyl 4-(2-iodoethoxy)-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)COCCI LLKNNWAVRRHMMC-UHFFFAOYSA-N 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RLKBOGLIOLFMEK-NSCUHMNNSA-N amino (e)-but-2-enoate Chemical compound C\C=C\C(=O)ON RLKBOGLIOLFMEK-NSCUHMNNSA-N 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910020366 ClO 4 Inorganic materials 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical group Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- RSBOYMJARBOYMP-UHFFFAOYSA-N ethyl 2-[(2-chlorophenyl)methylidene]-4-(2-iodoethoxy)-3-oxobutanoate Chemical compound ICCOCC(=O)C(C(=O)OCC)=CC1=CC=CC=C1Cl RSBOYMJARBOYMP-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- WSNAQLAHCVPEGN-UHFFFAOYSA-N 1-ethoxy-2h-pyridine Chemical class CCON1CC=CC=C1 WSNAQLAHCVPEGN-UHFFFAOYSA-N 0.000 description 1
- YOITUQVYKUCBMJ-UHFFFAOYSA-N 4-(2-aminoethoxy)-3-oxobutanoic acid Chemical compound NCCOCC(=O)CC(O)=O YOITUQVYKUCBMJ-UHFFFAOYSA-N 0.000 description 1
- RZDWUAGEAUZJHQ-UHFFFAOYSA-N 4-(2-chloroethoxy)-3-oxobutanoic acid Chemical compound OC(=O)CC(=O)COCCCl RZDWUAGEAUZJHQ-UHFFFAOYSA-N 0.000 description 1
- PLMCCOPFYJURPS-UHFFFAOYSA-N 4-bromo-3-oxobutanoic acid Chemical compound OC(=O)CC(=O)CBr PLMCCOPFYJURPS-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- MDXMRUQPSOETSG-UHFFFAOYSA-N acetic acid piperidine Chemical compound C(C)(=O)O.N1CCCCC1.C(C)(=O)O MDXMRUQPSOETSG-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 150000004729 acetoacetic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical class [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SYPJWLVJBCVLIE-UHFFFAOYSA-N ethyl 4-(2-chloroethoxy)-5-(2-chlorophenyl)-3-oxopent-4-enoate Chemical compound CCOC(=O)CC(=O)C(OCCCl)=CC1=CC=CC=C1Cl SYPJWLVJBCVLIE-UHFFFAOYSA-N 0.000 description 1
- RQCOPVYEHVOEMR-UHFFFAOYSA-N ethyl 4-ethoxy-3-oxobutanoate Chemical compound CCOCC(=O)CC(=O)OCC RQCOPVYEHVOEMR-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9701379A HU221810B1 (hu) | 1997-08-12 | 1997-08-12 | Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK104598A3 SK104598A3 (en) | 1999-03-12 |
| SK283422B6 true SK283422B6 (sk) | 2003-07-01 |
Family
ID=89995490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1045-98A SK283422B6 (sk) | 1997-08-12 | 1998-08-03 | Spôsob prípravy 3-etyl-5-metyl-2-(2-aminoetoxymetyl)-4-(2- chlórfenyl)-6-metyl-1,4-dihydro-3,5-pyridíndikarboxylátovej soli benzénsulfónovej kyseliny a medziprodukty na jej prípravu |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6046337A (pl) |
| EP (1) | EP0902016B1 (pl) |
| AT (1) | ATE216988T1 (pl) |
| CZ (1) | CZ291430B6 (pl) |
| DE (1) | DE69805143T2 (pl) |
| ES (1) | ES2175573T3 (pl) |
| HR (1) | HRP980440B1 (pl) |
| HU (1) | HU221810B1 (pl) |
| PL (2) | PL192097B1 (pl) |
| RU (1) | RU2163597C2 (pl) |
| SI (1) | SI0902016T1 (pl) |
| SK (1) | SK283422B6 (pl) |
| UA (1) | UA57722C2 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA72768C2 (en) * | 1999-07-05 | 2005-04-15 | Richter Gedeon Vegyeszet | A method for obtaining amilodipine benzenesulphonate |
| US7266501B2 (en) * | 2000-03-02 | 2007-09-04 | Akiba Electronics Institute Llc | Method and apparatus for accommodating primary content audio and secondary content remaining audio capability in the digital audio production process |
| ES2254495T4 (es) | 2000-12-29 | 2007-06-16 | Pfizer Limited | Hemimaleato de amlodipina. |
| EP1309556B1 (en) | 2000-12-29 | 2004-11-24 | Pfizer Limited | Amlodipine fumarate |
| WO2002053542A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Process for making amlodipine maleate |
| WO2002053541A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Amide derivative of amlodipine |
| AT5874U1 (de) | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
| MXPA03005882A (es) | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
| EP1346214A2 (en) | 2000-12-29 | 2003-09-24 | Pfizer Limited | Reference standards and processes for determining the purity or stability of amlodipine maleate |
| US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
| US6653481B2 (en) * | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
| GB2372036B (en) | 2000-12-29 | 2004-05-19 | Bioorg Bv | Aspartate derivative of amlodipine |
| KR100374767B1 (ko) * | 2001-03-13 | 2003-03-03 | 한미약품공업 주식회사 | 개선된 암로디핀의 제조 방법 |
| ATE454890T1 (de) * | 2001-07-06 | 2010-01-15 | Lek Pharmaceuticals | Verfahren zur herstellung hochreines amlodipinbenzolsulfonat |
| US6680334B2 (en) | 2001-08-28 | 2004-01-20 | Pfizer Inc | Crystalline material |
| US6828339B2 (en) * | 2001-11-21 | 2004-12-07 | Synthon Bv | Amlodipine salt forms and processes for preparing them |
| US6699892B2 (en) | 2002-06-04 | 2004-03-02 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salt of amlodipine and method of preparing the same |
| US6784297B2 (en) | 2002-09-04 | 2004-08-31 | Kopran Limited | Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate |
| US6608206B1 (en) * | 2002-10-30 | 2003-08-19 | Council Of Scientific & Industrial Research | Process for making S(-) Amlodipine salts |
| US20060030602A1 (en) * | 2004-03-16 | 2006-02-09 | Sepracor Inc. | (S)-amlodipine malate |
| KR100807336B1 (ko) | 2006-10-23 | 2008-02-28 | 명문제약주식회사 | 암로디핀의 제조를 위한 신규한 중간체 화합물, 이의 제조방법 및 이를 이용한 암로디핀의 제조 방법 |
| HU230877B1 (hu) * | 2008-09-30 | 2018-11-29 | EGIS Gyógyszergyár NyR | Stabil kombinációs gyógyszerkészítmény |
| CN102070516A (zh) * | 2011-02-22 | 2011-05-25 | 广东东阳光药业有限公司 | 一种制备氨氯地平的方法 |
| RU2755349C1 (ru) * | 2021-02-16 | 2021-09-15 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Применение бензил 6-({ 2-[(3,4-диметилфенил)амино]-2-оксоэтил} тио)-2-метил-4-(4-хлорфенил)-5-циано-1,4-дигидропиридин-3-карбоксилата в качестве гепатопротекторного средства |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| GB8608335D0 (en) * | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
| US5001119A (en) * | 1987-11-25 | 1991-03-19 | Schwartz Arthur G | 16-substituted androstanes and 16-substituted androstenes |
| EP0524974A1 (de) * | 1990-04-10 | 1993-02-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Pyridine als arzneimittel |
| US5389654A (en) * | 1992-11-26 | 1995-02-14 | Lek, Tovarna, Farmacevtskih In Kemicnih . . . | 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate |
| SI9200344B (sl) * | 1992-11-26 | 1998-06-30 | Lek, | Postopek za pripravo amlodipin benzensulfonata |
-
1997
- 1997-08-12 HU HU9701379A patent/HU221810B1/hu not_active IP Right Cessation
-
1998
- 1998-07-30 CZ CZ19982396A patent/CZ291430B6/cs not_active IP Right Cessation
- 1998-08-03 SK SK1045-98A patent/SK283422B6/sk unknown
- 1998-08-10 UA UA98084353A patent/UA57722C2/uk unknown
- 1998-08-11 PL PL375449A patent/PL192097B1/pl not_active IP Right Cessation
- 1998-08-11 HR HR980440A patent/HRP980440B1/xx not_active IP Right Cessation
- 1998-08-11 RU RU98115586/04A patent/RU2163597C2/ru not_active IP Right Cessation
- 1998-08-11 PL PL327952A patent/PL191995B1/pl not_active IP Right Cessation
- 1998-08-12 DE DE69805143T patent/DE69805143T2/de not_active Expired - Fee Related
- 1998-08-12 SI SI9830190T patent/SI0902016T1/xx unknown
- 1998-08-12 AT AT98115155T patent/ATE216988T1/de not_active IP Right Cessation
- 1998-08-12 EP EP98115155A patent/EP0902016B1/en not_active Expired - Lifetime
- 1998-08-12 ES ES98115155T patent/ES2175573T3/es not_active Expired - Lifetime
- 1998-08-12 US US09/133,108 patent/US6046337A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PL191995B1 (pl) | 2006-08-31 |
| PL327952A1 (en) | 1999-02-15 |
| US6046337A (en) | 2000-04-04 |
| PL192097B1 (pl) | 2006-08-31 |
| HUP9701379A3 (en) | 2000-06-28 |
| HU221810B1 (hu) | 2003-01-28 |
| DE69805143D1 (de) | 2002-06-06 |
| HUP9701379A2 (hu) | 2000-05-28 |
| UA57722C2 (uk) | 2003-07-15 |
| HRP980440A2 (en) | 1999-06-30 |
| CZ291430B6 (cs) | 2003-03-12 |
| RU2163597C2 (ru) | 2001-02-27 |
| CZ239698A3 (cs) | 1999-02-17 |
| DE69805143T2 (de) | 2002-11-28 |
| EP0902016A1 (en) | 1999-03-17 |
| SI0902016T1 (en) | 2002-08-31 |
| EP0902016B1 (en) | 2002-05-02 |
| HRP980440B1 (en) | 2003-06-30 |
| ES2175573T3 (es) | 2002-11-16 |
| ATE216988T1 (de) | 2002-05-15 |
| HU9701379D0 (en) | 1997-10-28 |
| EP0902016A3 (en) | 2000-01-05 |
| SK104598A3 (en) | 1999-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK283422B6 (sk) | Spôsob prípravy 3-etyl-5-metyl-2-(2-aminoetoxymetyl)-4-(2- chlórfenyl)-6-metyl-1,4-dihydro-3,5-pyridíndikarboxylátovej soli benzénsulfónovej kyseliny a medziprodukty na jej prípravu | |
| EP0153016B1 (en) | Asymmetrical diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid | |
| EP0529702B1 (en) | Dihydropyridine derivatives, their preparation and their use | |
| EP0902016A2 (en) | A process and intermediate compounds for the preparation of amlodipine benzene sulphonate | |
| EP1196383B1 (en) | Process for preparing amlodipine benzenesulphonate | |
| SU1662349A3 (ru) | Способ получени замещенных 1Н-имидазолов или их солей присоединени нетоксичных, фармацевтически приемлемых кислот | |
| EP0371492B1 (en) | Process for the preparation of 1,4-dihydropyridine derivatives | |
| KR100379058B1 (ko) | 디히드로피리딘유도체의제조방법 | |
| US5112978A (en) | Process for preparing alpha (alkyl phenyl)-4(hydroxy-diphenylmethyl)-1-piperidinyl butanol | |
| JP4031366B2 (ja) | アムロジピンの製造方法 | |
| EP0212340B1 (en) | 2-(heteroalkyl)-1,4-dihydropyridines, process for their preparations and pharmaceutical compositions containing them | |
| KR100374405B1 (ko) | 암로디핀 베실레이트의 제조방법 | |
| JPS6352031B2 (pl) | ||
| JP3275232B2 (ja) | ジヒドロピリジン誘導体の製法 | |
| US6248888B1 (en) | Process for the preparation of terazosin hydrochloride dihydrate | |
| US4634712A (en) | Antihypertensive esters of 1,4-dihydro-2,6-dimethyl-3-(alkoxycarbonyl or alkoxyalkoxycarbonyl)-4-(substituted phenyl)-pyridine-5-carboxylic acid | |
| KR100354806B1 (ko) | 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법 | |
| US7153970B2 (en) | High purity amlodipine benzenesulfonate and a process for its preparation | |
| KR100559800B1 (ko) | 메틸1,1,질소-트리메틸-(3,3-디페닐프로필)-2-아미노에틸-1,4-디하이드로-2,6-디메틸-4(3-니트로페닐)-피리딘-3,5-디카르복실레이트 하이드로클로라이드의 새로운 제조방법 | |
| GB2178738A (en) | Pharmaceutically active 1,4-Dihydropyridine sulfone derivatives and intermediates therefor | |
| WO2003101965A1 (en) | Two crystalline hydrate forms of amlodipine benzenesulfonate of high purity, processes for their preparation and use | |
| EP0109049A2 (en) | Process for preparation of substituted dihydropyridines and intermediates therefor | |
| WO2007131759A1 (en) | A process for the preparation of amlodipine benzenesulfonate | |
| KR20050122481A (ko) | 암로디핀 베실레이트염의 신규한 중간체 화합물 및 이를이용한 암로디핀 베실레이트염의 제조 방법 |